|
Passionate pediatrician
Dr. Terry Klassen is leading an effort to turn Winnipeg into a major centre of research for children's health
 |
| Katelin Moffatt (L) and Megan Reid get down to the business of colouring with Dr. Terry Klassen. |
|
BY DOLORES HAGGARTY
Winnipeg Health Region
Wave, May / June 2011
The parents were in
panic mode.
One day, their four-week-old baby boy
was the picture of good health. The next,
he was struggling to breathe, his little
chest heaving violently with each gasp
for air.
Now, they were in the emergency
department at Children's Hospital,
hopeful that the doctor on call that
day would be able to do something -
anything - to help their child.
By this time, the parents knew that their
baby was suffering from bronchiolitis
- an acute viral infection of the lower
respiratory tract that can afflict babies in
the first year of life.
What they didn't know was that the
man diagnosing and treating their infant
son on that day last February was Dr.
Terry Klassen, one of Canada's top
pediatric researchers and the man who
helped write the book on how to treat this
particular kind of infection.
Klassen first became interested in
bronchiolitis while working as a pediatric
physician in Ottawa during the late 1980s
and early 1990s. At the time, he realized
there were no definitive guidelines for
treating children with the condition.
"In some cases, doctors would
treat with ventolin or an oral dose of
theophylline, which could be toxic at
times," he says, recalling the challenges
faced by pediatricians. "In many cases,
the infant would have to be admitted to
hospital for further tests and treatment."
Then Klassen remembered that one
of his former professors in Manitoba,
Dr. Victor Chernick, a pediatric
pulmonologist with an international
reputation, had talked and written about
using epinephrine to treat bronchiolitis in
certain situations.
Klassen decided to test his teacher's
idea. Already conducting research into pediatric head injuries and croup,
Klassen added bronchiolitis to his list of
investigations. It took years of painstaking
work: getting money for research,
designing the studies, collaborating with
other health-care professionals across
Canada, and comparing information
on thousands of children. "It's not like
'bang,' and there's an answer." But an
answer finally did emerge: infants and
small children with acute bronchiolitis
react best to short-term treatment with
adrenaline/epinephrine.
This, then, was the knowledge
Klassen was able to carry comfortably
to the concerned family that day at the Children's Hospital. "At first, with all
his huffing and puffing and gasping
for breath, you worry his little lungs
might tire out and you might have to
put a tube in to help him breathe," says
Klassen. "And yet, we were able to give
a couple of epinephrine masks and he
turned a corner. So rather than end up in
intensive care, we were able to send him
to a pediatric ward."
Moments like these give meaning to
Klassen's work and generally underscore
the importance of research, especially
when it comes to enhancing care for
children. "It was a neat experience," he
says. "You take this evidence, you apply
it, it makes a difference in the child's life
and the parents may relax a bit. It keeps
you relevant, keeps you focused."
Klassen's passion for his work is
obvious. A quick look at his resume
reveals a list of achievements that would
be enough for several careers. In addition
to groundbreaking research and more
than 150 published articles, Klassen
has also played a key role in starting up
research departments almost from scratch
in Ottawa and Edmonton, and has
established or helped create a number
of national and international research
networks. In doing so, he has helped
redefine the nature of pediatric research
and care in Canada.
No surprise then that when the
Children's Hospital Foundation, working
with the University of Manitoba's Faculty
of Medicine, started looking last year for
a top-flight pediatrician and researcher
to lead the Manitoba Institute of Child
Health, they decided Terry Klassen was
their man.
Dr. Brian Postl, Dean of the University
of Manitoba's Faculty of Medicine, says
Klassen was an obvious choice. "He is
one of the premier pediatric researchers
in the country," says Postl, who is a
pediatrician and former President & CEO
of the Winnipeg Health Region. "He
sees health care and educating young
professionals from a broad population
health perspective. And, of course, he
has had experience in several health
systems across the country, and brings
that experience with a very mature,
thoughtful and visionary approach to the
roles he fulfills.
For Klassen, the offer was simply too
good to pass up.
Located at the Faculty's Bannatyne
campus, the Manitoba Institute of Child
Health is one of the province's bestkept
secrets. It was created in 2001 and
incorporated in 2007 by the Children's
Hospital Foundation Inc., working
in partnership with the University
of Manitoba's Faculty of Medicine,
Winnipeg Health Region and Health
Sciences Centre Children's Hospital.
With over 80 people on site and more
than 200 affiliated principal investigators
working on a range of projects at
facilities across Manitoba, MICH is
the largest research organization of its
kind on the Prairies, and enjoys a solid
reputation in the pediatric community.
As such, it also serves as a kind
of template for Manitoba's emerging
Academic Health Sciences Network,
which is being developed by the Region
and the University of Manitoba's Faculty
of Medicine. The idea is to use the
network to promote greater collaboration
in clinical, education and research
programs which will, in turn, enhance
clinical care for patients, training for
students and support for researchers. The
network will also make it easier to recruit
top-flight researchers to Manitoba.
Klassen's mission is to build on
MICH's record of achievement by taking
it to the next level and establishing it
as one of the finest institutes of its kind
anywhere in the world.
It's a tall order, but one that Klassen
embraces with all the enthusiasm that he
has displayed throughout his nearly 30-year career. The fact that he gets to do
it all in his home province is a bonus.
Born in 1957, Klassen is the son of
Mennonite missionaries and spent his
early years in Flin Flon and Central
America. By the time he entered his
teens, the family had returned to
Manitoba where Klassen went on to
medical school at the University of
Manitoba.
He describes himself at that time as
"a shy guy - understated but thoughtful
- with deep friendships." Shortly after
graduation from the University of
Manitoba in 1982, Klassen and his
family moved to Brandon where he
settled into a general pediatric practice.
A short while later, Klassen
responded to an advertisement in the
Canadian Medical Association Journal
for a full-time pediatric emergency
doctor at the Children's Hospital of
Eastern Ontario (CHEO). It would be a
major turning point in his life.
After what could be described as a
seminal meeting with Marilyn Li - then
Director of Pediatric Emergency at
CHEO - the young family moved to
Ottawa. Under Li's mentorship, Klassen
thrived. "She saw something in me that
others hadn't yet identified. She told me
I was going to be chief of a department
one day," he recalls.
At that time in Canada, there weren't
any specialized pediatric emergency
department doctors, nor were there any
training programs in that area.
Under Li's guidance, Klassen and
others led the way to developing the
definitive skill sets required to be a
pediatric emergency doctor. Eventually,
the Royal College of Physicians
and Surgeons of Canada developed
pediatric emergency medicine into a
two-year sub-specialty program.
Research was another requirement
on the job in Ottawa. This was a new
field for Klassen, and, being curious,
enthusiastic, and passionate, he threw
himself into the work.
It was heady stuff, working in
pediatric emergency and doing
research. And since that time, all of
his research has emerged from the
pediatric emergency department. "Peds
emergency is a rich environment," he
says. "The choices are never clear.
Many of my research questions have
emerged from hitting a perplexing
question as you care for children," he
says. "For instance, what is the best
way to do this and if there isn't any
answer, you have to research to find the
answer for children."
His work in Ottawa attracted the
attention of recruiters at Stollery
Children's Hospital in Alberta. In 1999,
he moved to Edmonton and became
Chair of the Department of Pediatrics
at the University of Alberta and the founding Director of the Alberta Research
Centre for Health Evidence.
It was there that Klassen proved to be a
formidable builder. Under his leadership,
Stollery developed a fully staffed 24-hour
pediatric emergency department. He also
carefully crafted the hospital into Western
Canada's main referral centre for pediatric
cardiac surgery. On the research side, he
increased research dollars from $4 million
to $20 million a year.
In 2010, though, after a year-long
sabbatical, he was at a crossroads in his
career. His initial plan was to continue
working primarily as a clinical scientist.
He had been awarded a major grant
of $200,000 a year for seven years
to work in knowledge translation.
(Simply put, knowledge translation is
working to exchange research ideas,
combine research knowledge, apply that
knowledge ethically and make it better
known to the larger community.)
That's when Manitoba beckoned.
"Manitoba came knocking and I really
listened. Just how often in life do you get
to come back home and be presented
a great opportunity at the right time in
your professional life? I came back to
Winnipeg because I was excited about
the job."
Klassen arrived in Winnipeg in
September 2010. Now, eight months
later, he is in building mode again. "I
was brought in to provide leadership, to
give vision, to give direction and to put
the right team in place to advance the
research here." He continues: "I need to
make MICH a wonderful, great research
institute that's advancing knowledge so
that we can dramatically improve the care
of the children and youth we serve."
And what does that entail? Klassen says
a well-run institute must be able to attract
top researchers and manage money.
But it must also be able to demonstrate
its success. One key measurement of
success will be how effective MICH is
in enhancing the delivery of care for
children. Another measurement will
be how much of the work done by
researchers at MICH is published in
respected medical research journals.
Philanthropy is also an important marker.
If the work has merit, it will gain attention
and attract donations to fund research at
the University of Manitoba and MICH.
And Klassen is clear as to how he will
reach his goals: "Through recruiting more
researchers and making those we have
more effective. We also need more grant
money to further their effectiveness and to
advance knowledge."
Klassen says the building blocks for
creating a great research institution are
already in place, and he suggests a tour of
the facility to hammer home the point.
Located on the fifth and sixth floors of
the John Buhler Research Centre, MICH
occupies 60,000 square feet, enveloped
in soft grays, blues and greens, with
touches of muted orange and yellow. It's
a state-of-the-art research environment
designed for aesthetics, function, safety
and comfort.
Klassen says MICH is already involved
in some high-profile research projects. As
an example, he singles out the Biology
of Breathing theme (BoB). Launched in
2003, BoB became the first theme-based
research group at MICH. It's described
as a multi-disciplinary program focused
specifically on pediatric respiratory
challenges such as asthma, the most
common chronic condition affecting
children in Canada today and the top
reason for children being admitted to
hospital.
The theme leader is Dr. Andrew
Halayko, an Associate Professor of
Internal Medicine and Physiology at
the University of Manitoba. Under his
leadership, more than 15 principal
investigators at the Faculty of Medicine
are working with other collaborating
investigators from diverse disciplines such
as physiology, pharmacology and internal
medicine to unlock some of the mysteries
of childhood lung diseases.
One interesting line of research centres
on the use of nanotechnology, which
involves testing drugs in artificial airways
made of synthetic material in which
human lung cells can grow. This research
was recently awarded a $1 million grant to be shared with British Columbia.
The size of the grant underscores the
importance of the work, says Klassen.
"People don't just dole out a million
bucks unless there's something important
going on. This is not just some little
research outfit. This is the big leagues."
Given the number of researchers at
MICH, it is impossible to highlight each
individual doing important work there.
Nevertheless, Klassen is comfortable
referring to Dr. Allan Becker as one of the
"star" researchers at the institute.
As a professor and Head of Allergy and
Clinical Immunology in the Department
of Pediatrics and Child Health at the
University of Manitoba's Faculty of
Medicine, Becker has spent nearly
two decades devoted to the study of
childhood asthma, investigating the
early-life origins of asthma in children.
His early study of asthma genes and
the environment included sending
questionnaires to the homes of 16,320
children born in Manitoba requesting
detailed information about family health
and the home environment.
His initial work showed that childhood
asthma could be reduced by nearly 60
per cent if babies were breastfed and
had limited exposure to allergy triggers
such as dust mites, animal dander and
tobacco smoke. Becker is currently Site
Leader and Co-Principal Investigator in
the Canadian Healthy Infant Longitudinal
Development Study. The objective of the
study is to track a group of 5,000 children
in Vancouver, Edmonton, Winnipeg and
Toronto from birth through age five to
examine the impact of environmental
factors on children's health.
"Studies like this are absolutely critical
if we're going to understand the origins
of diseases like asthma," says Becker.
"When we began our prevention study
in the early 1990s we thought we knew
everything that we needed to help prevent
this disease. Now we need to understand
a whole lot more."
The recruitment of moms and their
children is an important factor in a
research project like Becker's. According
to Klassen, Winnipeg scores high in
this area. "It seems like the Winnipeg
site has some intrinsic advantages over
some larger sites because of the closer
relationship between the team here and
obstetricians. They can make it happen
so the recruitment rates can be higher
and that is often the critical thing for the
success of the project," says Klassen.
Dr. Richard Keijzer, Assistant Professor
of Pediatric General Surgery at University
of Manitoba's Faculty of Medicine, is
another researcher creating a stir at
MICH. Klassen describes him as an
"absolutely brilliant pediatric surgeon"
who last year chose to come to MICH
from Rotterdam when he had the
opportunity to work just about anywhere
else in North America.
As a principal investigator with the BoB
group, Keijzer specializes in congenital
anomalies, with a special interest in
the repairs of congenital diaphragmatic
hernias. (These occur when the fetus's
diaphragm doesn't fully develop and the
abdominal organs push up into the tiny
chest, impeding proper lung formation.)
This life-threatening condition is often
picked up through a fetal assessment,
ensuring that preparations can be put in
place so that immediately after delivery
the newborn can be rushed to a neo-natal
intensive care unit where he or she is
quickly intubated (tubes inserted into the
air way) and placed on a ventilator. Once
the infant is fully stabilized, the hernia is
repaired surgically.
"I think Keijzer is going to make an
impact on that field," says Klassen. "He's
doing stellar work in trying to understand
why some children are born with a
diaphragmatic hernia, and at the same
time, he's a surgeon who came with an
exceptional clinical skill: he's doing what
we call minimally invasive surgery."
Another important avenue of
research centres on the work of Dr. Jon
McGavock, who has completed postdoctoral
studies in Kinesiology and
Recreation Management and works within
the Diabetes, Metabolism and Obesity
group, which is fast developing into
MICH's second major theme of study.
McGavock, an Assistant Professor
in Pediatrics & Child Health at the
University of Manitoba's Faculty of
Medicine, was recruited from Texas three
years ago and is described by Klassen
as one of the new breed of researchers.
Like others at MICH, McGavock had his
pick of placements: "I interviewed at
Texas, at McGill, at University of Toronto
and at University of Alberta, but MICH's
investment in me was 10 times higher
than anywhere else."
McGavock's research is focused on
Garden Hill, a northern First Nations
fly-in community of almost 4,000 Oji-
Cree people where Type 2 diabetes is 12
times higher than the national average.
Although some of his work takes
place in his office and lab, he spends
a great deal of time working within the
community. Over the past couple of
years, he has helped create a fitness
centre and is working on projects in
the school with an emphasis on peer
mentoring. The goal is for children to
develop relationships and self-esteem
and become more active. Diet also plays
a huge part, and to that end, McGavock
twice last year took 4,000 pounds of fresh
produce to the community. The produce
sold out in four hours.
He admits his goals are lofty: "We're
figuring out how to manage children with
Type 2 diabetes, we're figuring out who
is at risk of Type 2 diabetes, then we're
preventing Type 2 diabetes in high-risk
children. And, in the next few years, we
want Garden Hill to be known for its
innovative approaches to healthy living
rather than its lack of water and diabetes
rates."
Like Klassen, McGavock's passion is
contagious - not only for his concern
about the health of children, but also
for his zeal in demonstrating the lesserknown
benefits of research. "Here," he
says, pointing to a poster that reads:
Economic Benefit of Investing in Dr. Jon
McGavock's Lab. "This is where research
goes beyond health benefits."
Investment over three years from
MICH (through the Children's Hospital
Foundation) = $437,000; investment
from federal grants over same period =
$2,550,000; other monies invested in
program = $705,000. In other words, for
every dollar McGavock has received from
MICH, he has matched it seven times
over from other funding agencies.
And the benefits don't stop there.
McGavock directs attention to a
photograph of summer students who
worked in Garden Hill. "So these are
undergrad students who come in for
summer jobs, and these three now are
med students, this one came to work for
us and is now doing his master's in public
health because we encouraged him to go
back to school, and this is a PhD student
we recruited back from Montreal and . . . ."
He continues: "Inviting me to be here, I'm
just a drop, but if I can create 20 of these
(students) every four or five years, it's an
investment in people for Manitoba."
As Klassen continues his guided tour,
he moves to the sixth floor, where there is
still plenty of room for more researchers.
"In five years, we want this all filled up
with bustling activity," says Klassen,
pointing to an empty bank of lab space.
Then, bouncing back with his natural
positive spin, he says: "So you can see
they built this amazing space, so the
pressure on me is to get the best scientists
working here, but this is a phenomenal
recruitment tool because it's very
attractive."
Even with his abundance of positive
energy, Klassen knows the task ahead is
daunting. "I want to get the brightest and
the best," says Klassen. "I want to create
an environment where people will want
to come. I saw it happen at Stollery. Once
you get the momentum going - people
want to be there."
Dolores Haggarty is a Winnipeg writer.

 |
About Wave
Wave is published six times a year by the Winnipeg Health Region in cooperation with the Winnipeg Free Press. It is available at newsstands, hospitals and clinics throughout Winnipeg, as well as McNally Robinson Books.
Read the May / June 2011 issue of Wave |
|
|